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ABSTRACT
Gene Expression Atlas (http://www.ebi.ac.uk/gxa)
is an added-value database providing information
about gene expression in different cell types,
organism parts, developmental stages, disease
states, sample treatments and other biological/
experimental conditions. The content of this
database derives from curation, re-annotation and
statistical analysis of selected data from the
ArrayExpress Archive and the European Nucleotide
Archive. A simple interface allows the user to query
for differential gene expression either by gene
names or attributes or by biological conditions, e.g.
diseases, organism parts or cell types. Since our
previous report we made 20 monthly releases and,
as of Release 11.08 (August 2011), the database
supports 19 species, which contains expression
data measured for 19014 biological conditions in
136551 assays from 5598 independent studies.
INTRODUCTION
Two years ago, the European Bioinformatics Institute
(EBI) launched a new database called the Gene
Expression Atlas (the Atlas). The Atlas is a value-added
database for querying differential gene expression across
tissues, cell types and cell lines under various biological
conditions, including developmental stages, physiological
states, phenotypes and disease states, for multiple
organisms. Data in the Atlas come directly from the
ArrayExpress Archive of Functional Genomics
Experiments, including data imported from GEO (1).
We also now include data on microRNA expression as
well as next-generation sequencing RNA-Seq data from
the European Nucleotide Archive [ENA (2)].
Data sets imported in the Atlas are curated: microarray
probes and quantiﬁed RNA-seq transcripts are mapped to
the latest Ensembl genome builds (3), while sample attri-
butes are systematized and mapped to the Experimental
Factor Ontology (EFO) (4). Automatic statistical compu-
tations are performed, providing P-values and t-statistics
linking each gene to each experimental condition for all
studies. The Atlas query interface allows querying on
gene and sample attributes, with an advanced interface
for complex queries. A number of visual user interface
improvements have been made since the last release, and
a completely new interactive online training course is now
available at http://www.ebi.ac.uk/training.
Gene Expression Atlas can now be installed locally;
all content and source code is provided freely without
restrictions and without requirements to register.
As of September 2011, the EBI’s Gene Expression
Atlas contains data for over 370000 genes from nearly
6000 different independent studies, including more than
136000 samples representing nearly 20000 different bio-
logical conditions. Nineteen different species, including
human and model organisms, are included. Overall, this
represents a nearly 6-fold data volume increase compared
with results reported when Atlas was launched (5). The
database is updated monthly and is continuing to grow
constantly, both in terms of curated data sets, downloads
and hit rates.
RESULTS
Data and curation improvements
Global map of human gene expression. Work by Lukk
et al.( 6) on a large meta-analysis of human gene
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re-analysis of nearly 6000 microarray samples performed
on the Affymetrix U133A GeneChip
TM platform has been
loaded and integrated into the Atlas. The Functional
Genomics group has now produced two more data sets
of this nature, including a global mouse data re-analysis
(7) and an order-of-magnitude expansion of the human
Affymetrix data set (unpublished data). These new data
sets will be made available in the Atlas in the course
of 2012 as well.
MicroRNA curation. As planned in our previous report
(5), we have focused on microRNA data curation in the
Atlas. We re-annotate all microRNA chip designs in order
to avoid incorrect or incomplete annotations of probes
and incorrect probe-matching between different plat-
forms. All probes are matched, by exact sequence com-
parison, to the miRBase database latest version (8) and
are re-annotated with miRBase identiﬁers. This also
allows us to ensure that different platforms are maximally
comparable in the Atlas. Original manufacturers’ probe
identiﬁers are then replaced with matched miRBase
identiﬁers that are used uniformly in the Atlas.
RNA-Seq data processing. Early in 2011, we published
our R-based pipeline, ArrayExpressHTS, for processing
RNA-seq data sets (9). We integrated this pipeline in the
Atlas. All new submissions with RNA-seq data into
ArrayExpress Archive and European Nucleotide Archive
are put through ArrayExpressHTS. At the moment, we
are able to process automatically most RNA-seq experi-
ments on human, mouse and fruit ﬂy samples. From
45 human, 32 mouse and 64 ﬂy RNA-Seq data sets in
ArrayExpress in August 2011, 14 experiments have
been processed and loaded into Atlas, with 20 more to
be loaded before 2012. The pipeline uses bowtie (10)t o
align the reads and cufﬂinks (11) to quantify transcript
isoform expression levels.
Automation: mapping to EFO with Zooma. Zooma is a
bespoke application designed to automate the problem
of associating sample or assay annotations submitted by
data providers to ontology classes in EFO and other
ontologies. This process involves mapping the annota-
tions, which consist of a type (e.g. disease) and a value
(e.g. leukemia), to the appropriate ontology class (in this
case, EFO_0000565). Zooma automates this process by
searching for previously mapped instances of the same
annotation in the Atlas, exact text matches to EFO, and
also performs a search against the BioPortal (12) and
OLS (13) web services using OntoCAT (14). It uses a
simple ranking-based heuristic to evaluate the optimal
match and automatically writes any new mappings to
the Atlas database prior to each new data release.
Auto-updating genome annotations. Ensembl BioMart (15)
provides detailed annotations for genomic elements,
as well as regularly updated mappings for probes of
most microarray designs from major platforms, e.g.
Affymetrix and Illumina, to reference Ensembl genome
builds. We developed a subsystem within Atlas that
automatically checks the BioMart Central Portal for
new data releases and updates Atlas annotations. This
subsystem also enables the Atlas to support alternative
probe mappings and genomic annotations, e.g. custom
Affymetrix CDFs from the Bioconductor project (16),
or NCBI genome build annotations.
Improving Atlas statistics. The core statistical engine in
the Atlas remains the same: making use of the
Bioconductor package limma in combination with
structured curation of sample annotations to identify
experimental variables and automatically compute
per-factor contrasts. New to the Atlas is the reporting of
computed t-statistics together with P-values and sample
sizes on experiment pages and via API access routes.
User-interface features
Non-differentially expressed genes. The Atlas allows
searching for non-differentially expressed genes, i.e.
those with multiple testing-adjusted P values above the
signiﬁcance threshold of 0.05 in simultaneous t-test com-
parisons with global factor means. These ‘non-differential
expression’ results can be searched in the same way as
others: by gene and sample attributes from the Atlas
homepage, specifying ‘non-d.e.’ or ‘up/down/non-d.e.’ in
the query dropdown. Whereas over- and under-expression
results appear on red and blue backgrounds, respectively,
non-differential expression results are on white back-
ground (Figure 1).
Advanced interface features. We have introduced the
ability to ﬁlter results by specifying the number of experi-
ments in which a result is found, e.g. one can search for all
genes that appear as over-, under- or non-differentially
expressed in leukemia samples in at least ﬁve experiments.
Integration of Experimental Factor Ontology sample
attribute mappings has been improved: a more compact
ontology tree is displayed for large queries, with function-
ality to expand collapsed parts of the hierarchy and to
Figure 1. Example of non-differential expression results display.
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shows results aggregated for top-level ontology entries
such as ‘adenocarcinoma’ and ‘melanoma’, which in turn
can be further expanded. Also, one can navigate up
from ‘carcinoma’ to show results for other cancer types
(Figure 2).
Genome browser integration. Our RNA-Seq pipeline
ArrayExpressHTS saves short read alignments in as
BAM ﬁles. These ﬁles are incorporated into the Atlas
and are integrated into Atlas Experiment Pages: for
every transcript isoform identiﬁed by the pipeline, a link
is provided to the Ensembl Genome Browser, where
aligned reads are displayed as one of the tracks. Upon
new releases of the pipeline, its underlying tools and
reference genome builds, the alignments are rebuilt.
Anatomograms and mappings to the vertebrate bridging
ontology. We have developed several diagrammatic
vector representations of human, mouse and fruit ﬂy,
and propagated anatomical terms from the EFO into
these images. This allows highlighting and marking up
the images according to expression proﬁles. These
anatomograms, with highlighted tissues, are displayed on
individual gene pages in the Atlas, and are integrated in
EBI-wide search. The Vertebrate Bridging Ontology
(VBO) is an ontology of homologies between anatomical
structures across vertebrates, developed in the Functional
Genomics group (17). Cross-species homologous structure
annotations were imported into the EFO and are used to
enhance condition searches in the Atlas, expanding
multi-organism queries along these axes.
Integration with GeneSigDB. GeneSigDB, Gene Signature
Database is an expert-curated database of fully traceable,
standardized, annotated gene signature from published
research (18). We have collaborated closely with
GeneSigDB and have imported the latest (GeneSigDB
v4) set of signatures into the Atlas, enabling users to
search not only by individual gene or gene attribute, but
also by signature. For example, the famous van ‘t Veer
breast cancer signature (19) is represented by ID
11823860-Figure2 in GeneSigDB, and one can see the
expression proﬁles of these genes across all of Atlas by
entering this identiﬁer into the gene search box on the
home page.
Atlas infrastructure developments
Standalone Atlas. Starting from August 2010, we made
the Atlas into a standalone, installable software system
for managing transcriptomics data sets. Every month as
we make public releases of the EBI Gene Expression Atlas
website, simultaneously, we release the Atlas data and
software on the associated website (http://github.com/
gxa/gxa), with release notes, download and installation
instructions. The standalone Atlas is built with open-
source components and requires an Oracle database.
Standalone Atlas software provides a comprehensive
administration interface, which supports loading and
unloading data from the Atlas and performing various
maintenance tasks. The Atlas look and feel and some
aspects of its behavior can be adjusted via UI templates
and options in the Conﬁguration tab.
Distributed Atlas. A separate version of Atlas called
Distributed Atlas has been released, providing online
query federation among multiple Atlas deployments and
integration of results with conﬂict resolution. Distributed
Atlas uses a system of simple, powerful rules for
integrating distributed query results over multiple seman-
tically aligned Atlas instances within a single Atlas
interface, with natural extension and integration points.
We separated the Atlas into client and server parts,
allowing the client to communicate with multiple Atlas
servers, federating gene and condition queries
Figure 2. Example of compact ontology display for carcinoma results.
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possible query result conﬂicts:
(i) First Not Null: when assembling results from
multiple servers, the ﬁrst non-empty result is used.
This rule is used to integrate ontology- and
experiment-related queries.
(ii) Aggregation: multiple results of the same kind are
combined according to a pre-deﬁned statistical
integration strategy. For over/under expression
counts, results can be summed. Results with statis-
tical signiﬁcance measurements are combined using
meta-analytical strategies, e.g. using Fisher’s
method.
The Distributed Atlas user interface looks nearly identical
to the public EBI Atlas, except that the client can be
conﬁgured to communicate with multiple servers and
result pages include integrated results as well as subsections
of query results from individual servers. The software
is available at http://www.ebi.ac.uk/fg/gxa-distributed.
FUTURE DIRECTIONS
As Atlas data have grown >6-fold in the last year and
half, we are seeing that for a growing number of experi-
ments our statistical approach may not be best suited. We
have been developing alternative methods of statistical
analysis for complex multifactorial experiments and
will work on releasing these into production in 2012.
While in prior Atlas releases we have focused on pro-
cessed, normalized data as provided by original authors,
we are gradually switching to using raw data where
possible and reprocessing these data for best standardiza-
tion and comparability. For microRNA data sets, specif-
ically, we intend to combine data by platform and by
organism, identify common microRNAs and appropriate
low-signal intensity thresholds and renormalize the
data using cyclic lowness or quantile normalization
methods (20).
Lower costs and technological barriers have made
possible two comparatively new kinds of experiments:
large meta-analysis experiments, e.g. E-MTAB-62, the
global map of human gene expression (6), and large ref-
erence experiments such as the Illumina Body Map 2.0
data set. These experiments call for different statistics
and visualization approaches entirely, and work is
underway to make this possible.
We have made good progress this year with RNA-Seq
data processing and integration, but it is clear that we
have only scratched the surface of what is possible. Our
goal overall is to focus on NGS data in 2012. In particular,
we plan to process more high-throughput experiments
from ArrayExpress and the ENA and improve how we
handle other types of sequencing experiments, such as
small non-coding RNA-Seq and ChIP-Seq data.
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